IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


Oliver Künzler

Wenger Plattner

2025_IFLR1000_Notable_Practitioner_1_.png
Position: Partner/Head Corporate/M&A
Rating:
  • Notable practitioner
Bar Admissions:
Switzerland
Practice Areas:
M&A
Jurisdictions:
Languages:
German
English
French
Italian
Biography

Oliver is Partner at Wenger Plattner and heads the Practice Group Corporate & Commercial.

He deals primarily with international and national M&A transactions, restructurings and reorganisations, private equity and venture capital transactions and financings. Moreover, he has broad experience in advising shareholders and companies on aspects of contract, commercial and corporate law.

Recent transactional highlights
  • Advised AUDI as lead counsel with respect to its entry in Formula 1 as both power unit supplier as well as the takeover of shares in Sauber Group.
  • Advised Saurer Group on all Swiss legal aspects of the sale of three business units to Rieter. The purchase price for the three businesses is EUR 300 million on a cash and debt free basis.
  • Advised the leading healthcare investment firm Healthcare Royalty Management, LLC regarding the negotiation and conclusion of a purchase and sale agreement with ADC Therapeutics SA (all legal and tax aspects), regarding the purchase of revenue participation rights as well as the taking of collateral in the form of a bank account pledge over a locked box bank account for the royalty payments to be made by ADC under the purchase and sale agreement.
  • Advised Blue Water Biotech Inc., NASDAQ: BWV, on all Swiss legal aspects with respect to the acquisition of all shares in Proteomedix AG, a private, commercial-stage diagnostics oncology company. The parties also introduced a new name for the combined Company: Onconetix, Inc.
  • Advised Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities as lead advisor on all legal and tax aspects regarding the acquisition of 100 % of the shares in Lunaphore Technologies SA, a spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research.
Practice areas
  • Capital markets: Equity
  • Financial restructuring
  • M&A
  • Private equity
  • Structured finance/securitisation
Sector specialisations
  • Automotive
  • Consumer goods and services
  • Healthcare
  • Pharma and life sciences
  • Tech and telecoms
Association memberships
  • Zurich Bar Association
  • Swiss Bar Association
  • International Bar Association
Academic qualifications
  • Dr. iur. (PhD); University of Zurich
Address:
Zürich
Tel:+41 43 222 38 00 Email:Contact this practitioner Website:http://www.wenger-plattner.ch